148 related articles for article (PubMed ID: 10384389)
1. Problems in the detection of fatty acid oxidation defects: experience of a quality assurance programme for qualitative urinary organic acid analysis.
Downing M; Allen JC; Bonham JR; Edwards RG; Manning NJ; Olpin SE; Pollitt RJ
J Inherit Metab Dis; 1999 May; 22(3):289-92. PubMed ID: 10384389
[No Abstract] [Full Text] [Related]
2. Determination of total fatty acids in plasma: cis-5-tetradecenoic acid (C14:1 omega-9) in the diagnosis of long-chain fatty acid oxidation defects.
Divry P; Vianey-Saban C; Mathieu M
J Inherit Metab Dis; 1999 May; 22(3):286-8. PubMed ID: 10384388
[No Abstract] [Full Text] [Related]
3. Complications in early diagnosis and treatment of two infants with long-chain fatty acid beta-oxidation defects.
Skladal D; Sass JO; Geiger H; Geiger R; Mann C; Vreken P; Wanders RJ; Trawöger R
J Pediatr Gastroenterol Nutr; 2000 Oct; 31(4):448-52. PubMed ID: 11045847
[No Abstract] [Full Text] [Related]
4. Fatty acid oxidation in fibroblasts from patients with defects in beta-oxidation and in the respiratory chain.
Venizelos N; von Döbeln U; Hagenfeldt L
J Inherit Metab Dis; 1998 Jun; 21(4):409-15. PubMed ID: 9700598
[TBL] [Abstract][Full Text] [Related]
5. Organic acid profiles resembling a beta-oxidation defect in two patients with coeliac disease.
Costa CG; Verhoeven NM; Kneepkens CM; Douwes AC; Wanders RJ; de Almeida IT; Duran M; Jakobs C
J Inherit Metab Dis; 1996; 19(2):177-80. PubMed ID: 8739959
[No Abstract] [Full Text] [Related]
6. Secondary 3-hydroxydicarboxylic aciduria mimicking long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency.
Bennett MJ; Weinberger MJ; Sherwood WG; Burlina AB
J Inherit Metab Dis; 1994; 17(3):283-6. PubMed ID: 7807934
[No Abstract] [Full Text] [Related]
7. Fatty acid oxidation defects.
von Döbeln U
Acta Paediatr Suppl; 1993 Jun; 82 Suppl 389():88-90. PubMed ID: 8374203
[No Abstract] [Full Text] [Related]
8. Arrhythmias and conduction defects as presenting symptoms of fatty acid oxidation disorders in children.
Bonnet D; Martin D; Pascale De Lonlay ; Villain E; Jouvet P; Rabier D; Brivet M; Saudubray JM
Circulation; 1999 Nov; 100(22):2248-53. PubMed ID: 10577999
[TBL] [Abstract][Full Text] [Related]
9. Mitochondrial fatty acid beta-oxidation in the human eye and brain: implications for the retinopathy of long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency.
Tyni T; Paetau A; Strauss AW; Middleton B; Kivelä T
Pediatr Res; 2004 Nov; 56(5):744-50. PubMed ID: 15347768
[TBL] [Abstract][Full Text] [Related]
10. Quantitative analysis of urinary acylglycines for the diagnosis of beta-oxidation defects using GC-NCI-MS.
Costa CG; Guérand WS; Struys EA; Holwerda U; ten Brink HJ; Tavares de Almeida I; Duran M; Jakobs C
J Pharm Biomed Anal; 2000 Jan; 21(6):1215-24. PubMed ID: 10708405
[TBL] [Abstract][Full Text] [Related]
11. Analysis of 3-hydroxydodecanedioic acid for studies of fatty acid metabolic disorders: preparation of stable isotope standards.
Chickos JS; Way BA; Wilson J; Shaharuzzaman M; Laird J; Landt M
J Clin Lab Anal; 2002; 16(2):115-20. PubMed ID: 11948802
[TBL] [Abstract][Full Text] [Related]
12. [Metabolic crisis in an infant--is the problem in the mitochondria?].
Tyni T; Pihko H
Duodecim; 2002; 118(13):1331-9. PubMed ID: 12239878
[No Abstract] [Full Text] [Related]
13. Analysis of fatty acid oxidation intermediates in cultured fibroblasts to detect mitochondrial oxidation disorders.
Pourfarzam M; Schaefer J; Turnbull DM; Bartlett K
Clin Chem; 1994 Dec; 40(12):2267-75. PubMed ID: 7988014
[TBL] [Abstract][Full Text] [Related]
14. Octanoate and palmitate beta-oxidation in human leukocytes: implications for the rapid diagnosis of fatty acid beta-oxidation disorders.
Wanders RJ; Ijlst L; van Elk E; de Klerk JB; Przyrembel H
J Inherit Metab Dis; 1991; 14(3):317-20. PubMed ID: 1770782
[No Abstract] [Full Text] [Related]
15. Pigmentary retinopathy in long chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency.
Lawlor DP; Kalina RE
Am J Ophthalmol; 1997 Jun; 123(6):846-8. PubMed ID: 9535636
[TBL] [Abstract][Full Text] [Related]
16. Selective Screening of Fatty Acids Oxidation Defects and Organic Acidemias by Liquid Chromatography/tandem Mass Spectrometry Acylcarnitine Analysis in Brazilian Patients.
Vargas CR; Ribas GS; da Silva JM; Sitta A; Deon M; de Moura Coelho D; Wajner M
Arch Med Res; 2018 Apr; 49(3):205-212. PubMed ID: 30119976
[TBL] [Abstract][Full Text] [Related]
17. Accumulation of 3-hydroxy-fatty acids in the culture medium of long-chain L-3-hydroxyacyl CoA dehydrogenase (LCHAD) and mitochondrial trifunctional protein-deficient skin fibroblasts: implications for medium chain triglyceride dietary treatment of LCHAD deficiency.
Jones PM; Butt Y; Bennett MJ
Pediatr Res; 2003 May; 53(5):783-7. PubMed ID: 12621125
[TBL] [Abstract][Full Text] [Related]
18. [Mitochondrial 3-hydroxyacyl-CoA dehydrogenase (SCHAD, LCHAD)].
Yamaguchi S
Nihon Rinsho; 2002 Apr; 60 Suppl 4():101-4. PubMed ID: 12013827
[No Abstract] [Full Text] [Related]
19. Inborn errors of metabolism diagnosed in sudden death cases by acylcarnitine analysis of postmortem bile.
Rashed MS; Ozand PT; Bennett MJ; Barnard JJ; Govindaraju DR; Rinaldo P
Clin Chem; 1995 Aug; 41(8 Pt 1):1109-14. PubMed ID: 7628085
[TBL] [Abstract][Full Text] [Related]
20. Octanoylglucuronide excretion in patients with a defective oxidation of medium-chain fatty acids.
Duran M; Ketting D; van Vossen R; Beckeringh TE; Dorland L; Bruinvis L; Wadman SK
Clin Chim Acta; 1985 Nov; 152(3):253-60. PubMed ID: 4064333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
